APEX1 and cholangiocarcinoma: In our previous study, we showed that apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) can be a new CCA prognostic marker protein [8], since the serum APEX1 level of CCA patients with lymph node metastasis was significantly higher than that of patients without metastasis [8].